IL147774A0 - Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production - Google Patents
Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein productionInfo
- Publication number
- IL147774A0 IL147774A0 IL14777400A IL14777400A IL147774A0 IL 147774 A0 IL147774 A0 IL 147774A0 IL 14777400 A IL14777400 A IL 14777400A IL 14777400 A IL14777400 A IL 14777400A IL 147774 A0 IL147774 A0 IL 147774A0
- Authority
- IL
- Israel
- Prior art keywords
- aminolactams
- hydroxyalkanoyl
- inhibitors
- protein production
- related structures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15351199P | 1999-09-13 | 1999-09-13 | |
| US22438800P | 2000-08-09 | 2000-08-09 | |
| PCT/US2000/024967 WO2001019797A2 (en) | 1999-09-13 | 2000-09-13 | HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147774A0 true IL147774A0 (en) | 2002-08-14 |
Family
ID=26850619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14777400A IL147774A0 (en) | 1999-09-13 | 2000-09-13 | Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1212306A2 (zh) |
| JP (1) | JP2003509411A (zh) |
| CN (1) | CN1399634A (zh) |
| AU (1) | AU783914B2 (zh) |
| BR (1) | BR0014269A (zh) |
| CA (1) | CA2377221A1 (zh) |
| IL (1) | IL147774A0 (zh) |
| MX (1) | MXPA02001813A (zh) |
| WO (1) | WO2001019797A2 (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
| WO2001070672A2 (en) | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
| CA2403550A1 (en) * | 2000-04-03 | 2001-10-11 | Hong Liu | Cyclic lactams as inhibitors of a-.beta. protein production |
| US6632812B2 (en) * | 2000-04-11 | 2003-10-14 | Dupont Pharmaceuticals Company | Substituted lactams as inhibitors of Aβ protein production |
| AU2001261728A1 (en) | 2000-05-17 | 2001-11-26 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands for diagnostic imaging |
| GB0012671D0 (en) * | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| WO2003055850A1 (fr) * | 2001-12-27 | 2003-07-10 | Daiichi Pharmaceutical Co., Ltd. | Inhibiteurs de la production/secretion de la proteine amyloide-$g(b) |
| WO2003094854A2 (en) | 2002-05-07 | 2003-11-20 | Elan Pharmaceuticals, Inc. | Succinoyl aminopyrazoles and related compounds |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| EP1633350B1 (en) | 2003-06-05 | 2012-10-03 | Elan Pharmaceuticals, Inc. | Acylated amino acid amidyl pyrazoles and related compounds |
| EP2121633A2 (en) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| JP2010526825A (ja) | 2007-05-10 | 2010-08-05 | エーエムアール テクノロジー インコーポレイテッド | アリール置換およびヘテロアリール置換テトラヒドロベンゾ−１，４−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用 |
| WO2009082437A2 (en) | 2007-12-21 | 2009-07-02 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (sarms) and uses thereof |
| WO2009128057A2 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
| EP3094323A4 (en) | 2014-01-17 | 2017-10-11 | Ligand Pharmaceuticals Incorporated | Methods and compositions for modulating hormone levels |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
| AU729133B2 (en) * | 1996-11-22 | 2001-01-25 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| EA002100B1 (ru) | 1996-12-23 | 2001-12-24 | Элан Фармасьютикалз, Инк. | ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ |
| JP2003521438A (ja) * | 1997-12-22 | 2003-07-15 | エラン ファーマシューティカルズ，インコーポレイテッド | 多環式α−アミノ−ε−カプロラクタムおよび関連化合物 |
| AU4710499A (en) | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds |
| HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| IL142816A0 (en) | 1998-12-24 | 2002-03-10 | Du Pont Pharm Co | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
-
2000
- 2000-09-13 MX MXPA02001813A patent/MXPA02001813A/es unknown
- 2000-09-13 WO PCT/US2000/024967 patent/WO2001019797A2/en active IP Right Grant
- 2000-09-13 EP EP00963374A patent/EP1212306A2/en not_active Withdrawn
- 2000-09-13 IL IL14777400A patent/IL147774A0/xx unknown
- 2000-09-13 BR BR0014269-7A patent/BR0014269A/pt not_active Application Discontinuation
- 2000-09-13 CN CN00812784A patent/CN1399634A/zh active Pending
- 2000-09-13 CA CA002377221A patent/CA2377221A1/en not_active Abandoned
- 2000-09-13 AU AU74797/00A patent/AU783914B2/en not_active Ceased
- 2000-09-13 JP JP2001523377A patent/JP2003509411A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1212306A2 (en) | 2002-06-12 |
| AU7479700A (en) | 2001-04-17 |
| JP2003509411A (ja) | 2003-03-11 |
| AU783914B2 (en) | 2005-12-22 |
| CA2377221A1 (en) | 2001-03-22 |
| CN1399634A (zh) | 2003-02-26 |
| WO2001019797A2 (en) | 2001-03-22 |
| MXPA02001813A (es) | 2004-03-19 |
| WO2001019797A3 (en) | 2002-04-11 |
| BR0014269A (pt) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147774A0 (en) | Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production | |
| HUP0202705A3 (en) | Methods and microorganisms or production of panto-compounds | |
| IL149118A0 (en) | Inhibitors of neuraminidases | |
| IL142816A0 (en) | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
| GB2353810B (en) | Cutting elements and methods of manufacture thereof | |
| EP1539692A4 (en) | FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| GB0124299D0 (en) | Crystal structure of enzyme and uses thereof | |
| IL135261A0 (en) | Footwear and its method of construction | |
| EP1183030A4 (en) | PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE | |
| AU3622600A (en) | Metalloproteinases and methods of use therefor | |
| HK1044793A1 (en) | Mycotoxin-resistant transgenic wheat plant and methods of production and use thereof | |
| GB9924334D0 (en) | Pharmaceutical products and methods of fabrication therefor | |
| HUP0202519A2 (en) | Production of proteins | |
| PL352401A1 (en) | Method of making nitroguanidine and nitroenamine derivatives | |
| GB2359003B (en) | Method of and line for breadcrumb production | |
| DE60037236D1 (de) | Wechselstromgenerator und dessen Herstellungsverfahren | |
| AU3775500A (en) | Setting of gemstones | |
| AU2001257253A1 (en) | Asymmetric synthesis of piperazic acid and derivatives thereof | |
| PL340487A1 (en) | Macaroni and method of making same | |
| PL339487A1 (en) | Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same | |
| GB9924752D0 (en) | Method of construction | |
| GB9920906D0 (en) | Increased production of interferon-a | |
| IL149660A0 (en) | Use of enzymes for skin expansion | |
| SE9901516D0 (sv) | CVD-coated body and method of its production | |
| TW415179U (en) | Improved structure of earrings |